Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Polyester nasal swabs collected in a dry tube are a robust and inexpensive, minimal self-collection kit for SARS-CoV-2 testing

PLoS One. 2021 Apr 14;16(4):e0245423. doi: 10.1371/journal.pone.0245423. eCollection 2021.

Abstract

Background: In order to identify an inexpensive yet highly stable SARS-CoV-2 collection device as an alternative to foam swabs stored in transport media, both contrived ("surrogate") CoV-positive and patient-collected spun polyester swabs stored in dry tubes were evaluated for time- and temperature-stability using qPCR.

Methods: Surrogate specimens were prepared by combining multiple, residual SARS-CoV-2-positive clinical specimens and diluting to near-LOD levels in either porcine or human mucus ("matrix"), inoculating foam or polyester nasal swabs, and sealing in dry tubes. Swabs were then subjected to one of three temperature excursions: (1) 4°C for up to 72 hours; (2) 40°C for 12 hours, followed by 32°C for up to 60 hours; or (3) multiple freeze-thaw cycles (-20°C). The stability of extracted SARS-CoV-2 RNA for each condition was evaluated by qPCR. Separate usability studies for the dry polyester swab-based HealthPulse@home COVID-19 Specimen Collection Kit were later conducted in both adult and pediatric populations.

Results: Polyester swabs stored dry demonstrated equivalent performance to foam swabs for detection of low and moderate SARS-CoV-2 viral loads. Mimicking warm- and cold- climate shipment, surrogate specimens were stable following either 72 hours of a high-temperature excursion or two freeze-thaw cycles. In addition, usability studies comprised of self-collected patient specimens yielded sufficient material for molecular testing, as demonstrated by RNase P detection.

Conclusions: Polyester nasal swabs stored in dry collection tubes offer a robust and inexpensive self-collection method for SARS-CoV-2 viral load testing, as viral RNA remains stable under conditions required for home collection and shipment to the laboratory.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19 / diagnosis*
  • COVID-19 / virology*
  • COVID-19 Testing / methods
  • Clinical Laboratory Techniques / methods
  • Diagnostic Tests, Routine / methods
  • Humans
  • Molecular Diagnostic Techniques
  • Nasopharynx / virology
  • Polyesters
  • RNA, Viral / genetics
  • Real-Time Polymerase Chain Reaction / methods
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / isolation & purification*
  • Specimen Handling / methods*
  • Swine

Substances

  • Polyesters
  • RNA, Viral

Grants and funding

Funding for this project was provided primarily by the Bill and Melinda Gates Foundation, through a direct award (BMGF COVID Grant Investment ID: INV-016831) to Quantigen Biosciences (LRP, LAK, CLA, DKS, JSE, and DR) and Audere (SDC). The funder provided support in the form of salaries for authors (LRP, LAK, CLA, DKS, MLW, SDC, JSE, and DR) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section. Some reagents and consumables were provided free of charge to Quantigen by ThermoFisher. LRP, LAK, CLA, DKS, JSE, and DR are employed by Quantigen. YT is employed by The Everett Clinic-Part of Optum and MLW is employed by Sciest LLC.